Report cover image

Global TACE Embolic Microspheres Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 181 Pages
SKU # APRC20277346

Description

Summary

According to APO Research, The global TACE Embolic Microspheres market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for TACE Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for TACE Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for TACE Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for TACE Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of TACE Embolic Microspheres include ABK Biomedical, Boston Scientific, Merit Medical, Mermaid Medical, Sirtex Medical, Terumo, Varian, Cardiolink Science and Suzhou Hengrui Medical Equipment, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for TACE Embolic Microspheres, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of TACE Embolic Microspheres, also provides the sales of main regions and countries. Of the upcoming market potential for TACE Embolic Microspheres, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the TACE Embolic Microspheres sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global TACE Embolic Microspheres market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for TACE Embolic Microspheres sales, projected growth trends, production technology, application and end-user industry.

TACE Embolic Microspheres Segment by Company

ABK Biomedical
Boston Scientific
Merit Medical
Mermaid Medical
Sirtex Medical
Terumo
Varian
Cardiolink Science
Suzhou Hengrui Medical Equipment
TACE Embolic Microspheres Segment by Type

Common Embolic Microspheres
Drug-Loadable Embolic Microspheres
TACE Embolic Microspheres Segment by Application

Colorectal Cancer Liver Metastasis
Primary Liver Cancer
Others
TACE Embolic Microspheres Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TACE Embolic Microspheres market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of TACE Embolic Microspheres and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TACE Embolic Microspheres.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the TACE Embolic Microspheres market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of TACE Embolic Microspheres manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of TACE Embolic Microspheres in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of TACE Embolic Microspheres in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

181 Pages
1 Market Overview
1.1 Product Definition
1.2 Global TACE Embolic Microspheres Market Size, 2020 VS 2024 VS 2031
1.3 Global TACE Embolic Microspheres Market Size Estimates and Forecasts (2020-2031)
1.4 Global TACE Embolic Microspheres Sales Estimates and Forecasts (2020-2031)
1.5 Global TACE Embolic Microspheres Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global TACE Embolic Microspheres Market Dynamics
2.1 TACE Embolic Microspheres Industry Trends
2.2 TACE Embolic Microspheres Industry Drivers
2.3 TACE Embolic Microspheres Industry Opportunities and Challenges
2.4 TACE Embolic Microspheres Industry Restraints
3 TACE Embolic Microspheres Market by Manufacturers
3.1 Global TACE Embolic Microspheres Revenue by Manufacturers (2020-2025)
3.2 Global TACE Embolic Microspheres Sales by Manufacturers (2020-2025)
3.3 Global TACE Embolic Microspheres Average Sales Price by Manufacturers (2020-2025)
3.4 Global TACE Embolic Microspheres Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global TACE Embolic Microspheres Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global TACE Embolic Microspheres Manufacturers, Product Type & Application
3.7 Global TACE Embolic Microspheres Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global TACE Embolic Microspheres Market CR5 and HHI
3.8.2 Global Top 5 and 10 TACE Embolic Microspheres Players Market Share by Revenue in 2024
3.8.3 2024 TACE Embolic Microspheres Tier 1, Tier 2, and Tier 3
4 TACE Embolic Microspheres Market by Type
4.1 TACE Embolic Microspheres Type Introduction
4.1.1 Common Embolic Microspheres
4.1.2 Drug-Loadable Embolic Microspheres
4.2 Global TACE Embolic Microspheres Sales by Type
4.2.1 Global TACE Embolic Microspheres Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global TACE Embolic Microspheres Sales by Type (2020-2031)
4.2.3 Global TACE Embolic Microspheres Sales Market Share by Type (2020-2031)
4.3 Global TACE Embolic Microspheres Revenue by Type
4.3.1 Global TACE Embolic Microspheres Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global TACE Embolic Microspheres Revenue by Type (2020-2031)
4.3.3 Global TACE Embolic Microspheres Revenue Market Share by Type (2020-2031)
5 TACE Embolic Microspheres Market by Application
5.1 TACE Embolic Microspheres Application Introduction
5.1.1 Colorectal Cancer Liver Metastasis
5.1.2 Primary Liver Cancer
5.1.3 Others
5.2 Global TACE Embolic Microspheres Sales by Application
5.2.1 Global TACE Embolic Microspheres Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global TACE Embolic Microspheres Sales by Application (2020-2031)
5.2.3 Global TACE Embolic Microspheres Sales Market Share by Application (2020-2031)
5.3 Global TACE Embolic Microspheres Revenue by Application
5.3.1 Global TACE Embolic Microspheres Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global TACE Embolic Microspheres Revenue by Application (2020-2031)
5.3.3 Global TACE Embolic Microspheres Revenue Market Share by Application (2020-2031)
6 Global TACE Embolic Microspheres Sales by Region
6.1 Global TACE Embolic Microspheres Sales by Region: 2020 VS 2024 VS 2031
6.2 Global TACE Embolic Microspheres Sales by Region (2020-2031)
6.2.1 Global TACE Embolic Microspheres Sales by Region (2020-2025)
6.2.2 Global TACE Embolic Microspheres Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America TACE Embolic Microspheres Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America TACE Embolic Microspheres Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe TACE Embolic Microspheres Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe TACE Embolic Microspheres Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific TACE Embolic Microspheres Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific TACE Embolic Microspheres Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa TACE Embolic Microspheres Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa TACE Embolic Microspheres Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global TACE Embolic Microspheres Revenue by Region
7.1 Global TACE Embolic Microspheres Revenue by Region
7.1.1 Global TACE Embolic Microspheres Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global TACE Embolic Microspheres Revenue by Region (2020-2025)
7.1.3 Global TACE Embolic Microspheres Revenue by Region (2026-2031)
7.1.4 Global TACE Embolic Microspheres Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America TACE Embolic Microspheres Revenue (2020-2031)
7.2.2 North America TACE Embolic Microspheres Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe TACE Embolic Microspheres Revenue (2020-2031)
7.3.2 Europe TACE Embolic Microspheres Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific TACE Embolic Microspheres Revenue (2020-2031)
7.4.2 Asia-Pacific TACE Embolic Microspheres Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa TACE Embolic Microspheres Revenue (2020-2031)
7.5.2 South America, Middle East and Africa TACE Embolic Microspheres Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 ABK Biomedical
8.1.1 ABK Biomedical Comapny Information
8.1.2 ABK Biomedical Business Overview
8.1.3 ABK Biomedical TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 ABK Biomedical TACE Embolic Microspheres Product Portfolio
8.1.5 ABK Biomedical Recent Developments
8.2 Boston Scientific
8.2.1 Boston Scientific Comapny Information
8.2.2 Boston Scientific Business Overview
8.2.3 Boston Scientific TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Boston Scientific TACE Embolic Microspheres Product Portfolio
8.2.5 Boston Scientific Recent Developments
8.3 Merit Medical
8.3.1 Merit Medical Comapny Information
8.3.2 Merit Medical Business Overview
8.3.3 Merit Medical TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Merit Medical TACE Embolic Microspheres Product Portfolio
8.3.5 Merit Medical Recent Developments
8.4 Mermaid Medical
8.4.1 Mermaid Medical Comapny Information
8.4.2 Mermaid Medical Business Overview
8.4.3 Mermaid Medical TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Mermaid Medical TACE Embolic Microspheres Product Portfolio
8.4.5 Mermaid Medical Recent Developments
8.5 Sirtex Medical
8.5.1 Sirtex Medical Comapny Information
8.5.2 Sirtex Medical Business Overview
8.5.3 Sirtex Medical TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Sirtex Medical TACE Embolic Microspheres Product Portfolio
8.5.5 Sirtex Medical Recent Developments
8.6 Terumo
8.6.1 Terumo Comapny Information
8.6.2 Terumo Business Overview
8.6.3 Terumo TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Terumo TACE Embolic Microspheres Product Portfolio
8.6.5 Terumo Recent Developments
8.7 Varian
8.7.1 Varian Comapny Information
8.7.2 Varian Business Overview
8.7.3 Varian TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Varian TACE Embolic Microspheres Product Portfolio
8.7.5 Varian Recent Developments
8.8 Cardiolink Science
8.8.1 Cardiolink Science Comapny Information
8.8.2 Cardiolink Science Business Overview
8.8.3 Cardiolink Science TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Cardiolink Science TACE Embolic Microspheres Product Portfolio
8.8.5 Cardiolink Science Recent Developments
8.9 Suzhou Hengrui Medical Equipment
8.9.1 Suzhou Hengrui Medical Equipment Comapny Information
8.9.2 Suzhou Hengrui Medical Equipment Business Overview
8.9.3 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product Portfolio
8.9.5 Suzhou Hengrui Medical Equipment Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 TACE Embolic Microspheres Value Chain Analysis
9.1.1 TACE Embolic Microspheres Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 TACE Embolic Microspheres Production Mode & Process
9.2 TACE Embolic Microspheres Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 TACE Embolic Microspheres Distributors
9.2.3 TACE Embolic Microspheres Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.